description
The tumor suppressor TP53 (p53) exerts its tumor suppressive role in part by regulating transcription of a number of genes involved in cell death, mainly apoptotic cell death. The majority of apoptotic genes that are transcriptional targets of TP53 promote apoptosis, but there are also several TP53 target genes that inhibit apoptosis, providing cells with an opportunity to attempt to repair the damage and/or recover from stress. Pro-apoptotic transcriptional targets of TP53 involve TRAIL death receptors TNFRSF10A (DR4), TNFRSF10B (DR5), TNFRSF10C (DcR1) and TNFRSF10D (DcR2), as well as the FASL/CD95L death receptor FAS (CD95). TRAIL receptors and FAS induce pro-apoptotic signaling in response to external stimuli via extrinsic apoptosis pathway (Wu et al. 1997, Takimoto et al. 2000, Guan et al. 2001, Liu et al. 2004, Ruiz de Almodovar et al. 2004, Liu et al. 2005, Schilling et al. 2009, Wilson et al. 2013). IGFBP3 is a transcriptional target of TP53 that may serve as a ligand for a novel death receptor TMEM219 (Buckbinder et al. 1995, Ingermann et al. 2010).TP53 regulates expression of a number of genes involved in the intrinsic apoptosis pathway, triggered by the cellular stress. Some of TP53 targets, such as BAX, BID, PMAIP1 (NOXA), BBC3 (PUMA) and probably BNIP3L, AIFM2, STEAP3, TRIAP1 and TP53AIP1, regulate the permeability of the mitochondrial membrane and/or cytochrome C release (Miyashita and Reed 1995, Oda et al. 2000, Samuels-Lev et al. 2001, Nakano and Vousden 2001, Sax et al. 2002, Passer et al. 2003, Bergamaschi et al. 2004, Li et al. 2004, Fei et al. 2004, Wu et al. 2004, Park and Nakamura 2005, Patel et al. 2008, Wang et al. 2012, Wilson et al. 2013). Other pro-apoptotic genes, either involved in the intrinsic apoptosis pathway, extrinsic apoptosis pathway or pyroptosis (inflammation-related cell death), which are transcriptionally regulated by TP53 are cytosolic caspase activators, such as APAF1, PIDD1, and NLRC4, and caspases themselves, such as CASP1, CASP6 and CASP10 (Lin et al. 2000, Robles et al. 2001, Gupta et al. 2001, MacLachlan and El-Deiry 2002, Rikhof et al. 2003, Sadasivam et al. 2005, Brough and Rothwell 2007).It is uncertain how exactly some of the pro-apoptotic TP53 targets, such as TP53I3 (PIG3), RABGGTA, BCL2L14, BCL6, NDRG1 and PERP contribute to apoptosis (Attardi et al. 2000, Guo et al. 2001, Samuels-Lev et al. 2001, Contente et al. 2002, Ihrie et al. 2003, Bergamaschi et al. 2004, Stein et al. 2004, Phan and Dalla-Favera 2004, Jen and Cheung 2005, Margalit et al. 2006, Zhang et al. 2007, Saito et al. 2009, Davies et al. 2009, Giam et al. 2012).TP53 is stabilized in response to cellular stress by phosphorylation on at least serine residues S15 and S20. Since TP53 stabilization precedes the activation of cell death genes, the TP53 tetramer phosphorylated at S15 and S20 is shown as a regulator of pro-apoptotic/pro-cell death genes. Some pro-apoptotic TP53 target genes, such as TP53AIP1, require additional phosphorylation of TP53 at serine residue S46 (Oda et al. 2000, Taira et al. 2007). Phosphorylation of TP53 at S46 is regulated by another TP53 pro-apoptotic target, TP53INP1 (Okamura et al. 2001, Tomasini et al. 2003). Additional post-translational modifications of TP53 may be involved in transcriptional regulation of genes presented in this pathway and this information will be included as evidence becomes available.Activation of some pro-apoptotic TP53 targets, such as BAX, FAS, BBC3 (PUMA) and TP53I3 (PIG3) requires the presence of the complex of TP53 and an ASPP protein, either PPP1R13B (ASPP1) or TP53BP2 (ASPP2) (Samuels-Lev et al. 2001, Bergamaschi et al. 2004, Patel et al. 2008, Wilson et al. 2013), indicating how the interaction with specific co-factors modulates the cellular response/outcome.TP53 family members TP63 and or TP73 can also activate some of the pro-apoptotic TP53 targets, such as FAS, BAX, BBC3 (PUMA), TP53I3 (PIG3), CASP1 and PERP (Bergamaschi et al. 2004, Jain et al. 2005, Ihrie et al. 2005, Patel et al. 2008, Schilling et al. 2009, Celardo et al. 2013). For a review of the role of TP53 in apoptosis and pro-apoptotic transcriptional targets of TP53, please refer to Riley et al. 2008, Murray-Zmijewski et al. 2008, Bieging et al. 2014, Kruiswijk et al. 2015

external resources
NCBI:1383066
REACTOME:R-HSA-5633008
PUBMED:20353938
PUBMED:18676979
PUBMED:11511362
PUBMED:11919562
PUBMED:10973264
PUBMED:15797384
PUBMED:17442733
PUBMED:15607964
PUBMED:11278253
PUBMED:23059823
PUBMED:19549844
PUBMED:11684014
PUBMED:7566179
PUBMED:17349958
PUBMED:24739573
PUBMED:18719709
PUBMED:17284521
PUBMED:23703390
PUBMED:10807576
PUBMED:10733530
PUBMED:12402042
PUBMED:12851404
PUBMED:14729977
PUBMED:18431400
PUBMED:15377670
PUBMED:12089322
PUBMED:15273740
PUBMED:11382926
PUBMED:12606722
PUBMED:14623878
PUBMED:15577913
PUBMED:16230375
PUBMED:26122615
PUBMED:11559530
PUBMED:11054413
PUBMED:22766503
PUBMED:11463392
PUBMED:16249378
PUBMED:9326928
PUBMED:14614825
PUBMED:19615968
PUBMED:16140933
PUBMED:7834749
PUBMED:16135520
PUBMED:15126337
PUBMED:15580302
PUBMED:15289308
PUBMED:10777207
PUBMED:23365256
PUBMED:19040420
PUBMED:15735003
PUBMED:14688482

genes
APAF1 , BIRC5 , FAS , ATM , BAX , BCL6 , BID , BNIP3L , CASP1 , CASP2 , CASP6 , CASP10 , CHM , CREBBP , IGFBP3 , PMAIP1 , RABGGTA , RABGGTB , TP53 , TP53BP2 , TP73 , TP63 , CRADD , TNFRSF10D , TNFRSF10C , TNFRSF10B , TNFRSF10A , TP53I3 , NDRG1 , PRELID3A , PPP1R13B , BBC3 , PRELID1 , TRIAP1 , STEAP3 , PIDD1 , NLRC4 , TP53AIP1 , PERP , BCL2L14 , AIFM2 , TP53INP1 , TMEM219 , ZNF420 , MIR3191 ,